Search Through All Notices
June 20, 2022
MEMORANDUM
To: All Senators, Stakeholders and Media
From: Speaker Therese M. Terlaje, Chairperson
Subject: NOTICE of Join Public Hearing – Monday, June 27, 2022, beginning at 1:00 PM
Buenas yan Håfa Adai,
Please be advised that the Committee on Health, Land, Justice, and Culture in conjunction with the Department of Public Health & Social Services, Bureau of Health Care Financing Administration Division will convene a joint public hearing, on Monday, June 27, 2022, beginning at 1:00 PM in the Guam Congress Building, Public Hearing Room, for the following agenda item:
· Guam Medicaid – Medicaid Drug Rebate Program (MDRP), 1115 Waiver Demonstration Presentation (30 minutes)
The Guam Medicaid Program, administered under the Department of Public Health and Social Services (DPHSS), Division of Public Welfare will conduct a Public Hearing notifying island residents, program recipients & providers, and all other stakeholders of its intent to submit to the Centers for Medicare and Medicaid Services (CMS), on or before August 1, 2022, a written 1115 Demonstration application which will request to waive the mandate for the Guam Medicaid Program to participate in the Medicaid Drug Rebate Program (MDRP) and to receive comments on the proposed MDRP 1115 Waiver Demonstration application.
The CMS final rule (CMS-2345-FC) allows the territories to “opt out under…section 1902(j) of the Act.” It is through this waiver authority, that the Guam Medicaid Program is electing to apply under section 1115(a)(1) of the Act to waive section 1902(a)(54), which requires state compliance with applicable requirements of section 1927 requiring Guam Medicaid to participate in the Medicaid Drug Rebate Program (MDRP) by January 2023.
This 1115 waiver demonstration project will allow for a period for the Guam Medicaid Program to conduct a demonstration study on the potential adverse effects of participation in the MDRP on our island pharmacy providers and program recipients. The 1115 Waivers are generally approved by CMS for an initial five (5) year period and can be extended.
Presentation By: Michael Q. Gallo, Program Coordinator, Guam Medicaid Program
Guam Medicaid Recipients, Pharmacy Providers, and other Stakeholders are invited to provide oral or written testimony. Written testimony may be submitted via email to michael.gallo@dphss.guam.gov or jeffrey.sannicolas@dphss.guam.gov. or hand delivered to Guam Medicaid Program, #130 University Drive, Suite 5 Castle Mall Building, Mangilao, Guam 96913.
All hearings broadcast on GTA TV Channel 21, Docomo Channel 117/112.4, and livestream on https://www.youtube.com/c/GuamLegislatureMedia. In compliance with the Americans with Disabilities Act, Individuals needing special accommodations can contact the Office of Speaker Therese M. Terlaje.
MEMORANDUM
To: All Senators, Stakeholders and Media
From: Speaker Therese M. Terlaje, Chairperson
Subject: NOTICE of Join Public Hearing – Monday, June 27, 2022, beginning at 1:00 PM
Buenas yan Håfa Adai,
Please be advised that the Committee on Health, Land, Justice, and Culture in conjunction with the Department of Public Health & Social Services, Bureau of Health Care Financing Administration Division will convene a joint public hearing, on Monday, June 27, 2022, beginning at 1:00 PM in the Guam Congress Building, Public Hearing Room, for the following agenda item:
· Guam Medicaid – Medicaid Drug Rebate Program (MDRP), 1115 Waiver Demonstration Presentation (30 minutes)
The Guam Medicaid Program, administered under the Department of Public Health and Social Services (DPHSS), Division of Public Welfare will conduct a Public Hearing notifying island residents, program recipients & providers, and all other stakeholders of its intent to submit to the Centers for Medicare and Medicaid Services (CMS), on or before August 1, 2022, a written 1115 Demonstration application which will request to waive the mandate for the Guam Medicaid Program to participate in the Medicaid Drug Rebate Program (MDRP) and to receive comments on the proposed MDRP 1115 Waiver Demonstration application.
The CMS final rule (CMS-2345-FC) allows the territories to “opt out under…section 1902(j) of the Act.” It is through this waiver authority, that the Guam Medicaid Program is electing to apply under section 1115(a)(1) of the Act to waive section 1902(a)(54), which requires state compliance with applicable requirements of section 1927 requiring Guam Medicaid to participate in the Medicaid Drug Rebate Program (MDRP) by January 2023.
This 1115 waiver demonstration project will allow for a period for the Guam Medicaid Program to conduct a demonstration study on the potential adverse effects of participation in the MDRP on our island pharmacy providers and program recipients. The 1115 Waivers are generally approved by CMS for an initial five (5) year period and can be extended.
Presentation By: Michael Q. Gallo, Program Coordinator, Guam Medicaid Program
Guam Medicaid Recipients, Pharmacy Providers, and other Stakeholders are invited to provide oral or written testimony. Written testimony may be submitted via email to michael.gallo@dphss.guam.gov or jeffrey.sannicolas@dphss.guam.gov. or hand delivered to Guam Medicaid Program, #130 University Drive, Suite 5 Castle Mall Building, Mangilao, Guam 96913.
All hearings broadcast on GTA TV Channel 21, Docomo Channel 117/112.4, and livestream on https://www.youtube.com/c/GuamLegislatureMedia. In compliance with the Americans with Disabilities Act, Individuals needing special accommodations can contact the Office of Speaker Therese M. Terlaje.
